$25,500,000 Autocallable Index-Linked Notes due April 19, 2024, priced on April 15, 2021, were issued by GS Finance Corp. The pricing supplement for this note (CUSIP: 40057FZT4) can be found here. The notes had a $1,000 face value and only paid a fixed amount when the notes are called before maturity. No intermediate coupon was paid before they were called or matured. If not previously called, at maturity, the notes returned $1,000 in principal plus a fixed coupon or an income linked to the performance of the underlying if and S&P Biotechnology Select Industry Index all closed on the final determination date on April 16, 2024 and above 0% of their April 15, 2021 closing prices. If on April 16, 2024 and S&P Biotechnology Select Industry Index closed below 0% of their April 15, 2021 closing prices, the notes paid reduced principal euqal to $1,000 multiplied by the lowest ratio of and S&P Biotechnology Select Industry Index April 16, 2024 closing prices to their April 15, 2021 closing prices. The notes have matured. They paid $621.08 in principal repayment per $1,000 note. Investors thus suffered capital losses of $378.92.† In the aggregate, investors in this note suffered $9,662,461 in capital losses. See Table 1 and Figure 1.
SLCG Economic Consulting, LLC ("SLCG") specializes in finance, economics, and investment management consulting services. We offer expert witness services tailored to meet the needs of law firms, banks, brokerage firms, and individuals navigating complex litigation. Our team predominantly comprises PhD and MA-level professionals with varied backgrounds spanning academia, industry, and government. Numerous team members have offered expert testimony in state and federal courts, as well as in diverse arbitration forums. SLCG is a wholly owned subsidiary of McCann Yan Holdings, Inc., a Virginia incorporated company based in Northern Virginia.